Workflow
济川药业(600566) - 2023 Q3 - 季度财报
600566JUMPCAN(600566)2023-10-22 16:00

Financial Performance - The company's operating revenue for Q3 2023 was ¥1,907,788,905.65, representing a decrease of 6.05% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥604,314,013.26, an increase of 4.82% year-on-year[5]. - The net profit after deducting non-recurring gains and losses for Q3 2023 was ¥580,892,254.03, up 6.42% from the previous year[6]. - The basic earnings per share for Q3 2023 was ¥0.66, reflecting an increase of 1.69% compared to the same period last year[6]. - Total operating revenue for the first three quarters of 2023 reached ¥6,536,764,954.98, an increase of 10.9% compared to ¥5,893,672,580.32 in the same period of 2022[19]. - Net profit attributable to the parent company reached ¥7,969,266,454.41, up from ¥6,836,219,201.55, indicating a growth of 16.6%[16]. - The net profit for the third quarter of 2023 was CNY 1,944,157,913.66, an increase of 22.1% compared to CNY 1,592,113,444.33 in the same period of 2022[21]. - The total comprehensive income for the third quarter of 2023 reached CNY 1,947,379,873.64, up from CNY 1,593,329,185.71 in the previous year, reflecting a growth of 22.2%[21]. - Basic earnings per share for Q3 2023 were CNY 2.123, compared to CNY 1.792 in Q3 2022, representing an increase of 18.5%[21]. - The operating profit for Q3 2023 was CNY 2,224,683,531.19, up from CNY 1,772,551,376.54 in the same quarter of 2022, reflecting a growth of 25.5%[20]. Assets and Liabilities - The total assets as of September 30, 2023, amounted to ¥16,600,654,563.75, a growth of 10.81% from the end of the previous year[6]. - Total assets amounted to ¥16,600,654,563.75, compared to ¥14,981,202,241.23, representing an increase of 10.8%[18]. - Total liabilities increased to ¥4,116,734,291.55 from ¥3,628,677,198.27, reflecting a rise of 13.4%[18]. - The total equity attributable to shareholders reached ¥12,465,558,820.60, compared to ¥11,337,385,551.34, showing an increase of 10.0%[16]. Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 41.42%, primarily due to increased sales collection[10]. - Cash flow from operating activities for the first three quarters of 2023 was CNY 8,683,452,611.32, compared to CNY 7,338,564,505.99 in the same period last year, indicating a growth of 18.4%[23]. - The net cash flow from investing activities for the third quarter of 2023 was CNY 406,529,472.64, a significant recovery from a negative CNY 2,252,432,949.95 in Q3 2022[23]. - The net cash flow from financing activities for Q3 2023 was negative CNY 409,080,913.88, an improvement from negative CNY 508,366,392.32 in the same quarter of the previous year[24]. - The total cash and cash equivalents at the end of Q3 2023 amounted to CNY 7,676,028,547.73, up from CNY 3,080,299,599.00 at the end of Q3 2022, showing a growth of 149.1%[24]. - The company's cash and cash equivalents were reported at ¥12,779,125,973.11, up from ¥11,176,697,649.24, indicating a growth of 14.3%[16]. Expenses and Investments - Total operating costs for the same period were ¥4,458,429,019.85, up from ¥4,214,599,136.63, reflecting a year-over-year increase of 5.8%[19]. - Research and development expenses increased to ¥334,603,477.50, compared to ¥252,530,629.98 in the previous year, marking a rise of 32.4%[19]. - The company reported a credit impairment loss of CNY 42,613,248.89 in Q3 2023, compared to CNY 6,763,988.04 in Q3 2022, indicating a significant increase in credit risk[20]. - The company’s long-term investments increased to ¥16,297,234.85 from ¥13,938,019.75, reflecting a growth of 16.9%[16]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,062[11]. - The weighted average return on equity for Q3 2023 was 4.99%, a decrease of 0.84 percentage points compared to the previous year[6]. - The company received government subsidies amounting to ¥7,006,882.35 during Q3 2023, with a total of ¥44,896,303.92 for the year-to-date[7].